Heron Therapeutics Inc (NASDAQ:HRTX)

Monday’s Trading Day
29.47 -0.80 / -2.66%
As of Jun 29
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
30.00 +0.54 / +1.82%
 
Volume: 3.1K

Today’s Trading

Previous close30.27
Today’s open29.23
Day’s range-- - --
Volume973,135
Average volume (3 months)1,390,351
Market cap$1.0B
Dividend yield--
Data as of 06/29/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+0.81%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book13.66

Competitors

 Today’s
change
Today’s
% change
ARNAArena Pharmaceutical...-0.09-2.05%
PDLIPDL BioPharma Inc-0.15-2.30%
ARRYArray Biopharma Inc-0.37-4.98%
MGNXMacroGenics Inc-0.75-2.06%
Data as of 06/29/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers